Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

438

Participants

Timeline

Start Date

November 1, 2010

Primary Completion Date

January 1, 2012

Study Completion Date

February 1, 2012

Conditions
Asthma
Interventions
DRUG

Placebo

Matching placebo administered orally twice daily

DRUG

Setipiprant

ACT-129968 (Dose 1, Dose 2, or Dose 3) administered orally twice daily

Trial Locations (97)

1036

Clinical Investigative Site 5310, Budapest

1431

Clinical Investigative Site # 5101, Sofia

Clinical Investigative Site # 5104, Sofia

1829

Clinical Investigative Site 5906, Johannesburg

2037

Clinical Investigative Site 5002, Glebe

3529

Clinical Investigative Site 5304, Miskolc

3980

Clinical Investigative Site 5309, Sátoraljaújhely

4001

Clinical Investigative Site 5901, Durban

4075

Clinical Investigative Site 5001, Sherwood

4400

Clinical Investigative Site # 5303, Nyíregyháza

6003

Clinical Investigative Site # 5102, Stara Zagora

6009

Clinical Investigative Site 5003, Nedlands

6045

Clinical Investigative Site 5910, Port Elizabeth

6529

Clinical Investigative Site 5909, George

7002

Clinical Investigative Site # 5103, Rousse

7530

Clinical Investigative Site 5905, Cape Town

7700

Clinical Ivestigative Site 5902, Cape Town

8600

Clinical Investigative Site 5301, Siófok

9300

Clinical Investigative Site 5307, Csorna

Clinical Investigative Site 5908, Bloemfontein

9400

Clinical Investigative Site # 5308, Sopron

10461

Clinical Investigative Site 6205, The Bronx

10969

Clinical Investigative Site 5208, Berlin

11080

Clinical Investigative Site 5701, Belgrade

Clinical Investigative Site 5702, Belgrade

12165

Clinical Investigative Site 5212, Berlin

15562

Clinical Investigative Site 5202, Rüdersdorf

19107

Clinical Investigative Site 6203, Philadelphia

20357

Clinical Investigative Site 5211, Hamburg

22185

Clinical Investigative Site 6052, Lund

23552

Clinical Investigative 5209, Lübeck

27157

Clinical Investigative Site # 6223, Winston-Salem

29303

Clinical Investigative Site 6230, Spartanburg

29615

Clinical Investigative Site # 6228, Greenville

32308

Clinical Investigative Site # 6219, Tallahassee

34362

Clinical Investigative Site 5401, Haifa

36028

Clinical Investigative Site 6108, Poltava

37208

Clinical Investigative Site 6226, Nashville

37909

Clinical Investigative Site 6202, Knoxville

44263

Clinical Investigative Site 5205, Dortmund

49100

Clinical Investigative Site 5405, Petach Tikvah

53792

Clinical Investigative Site # 6217, Madison

55116

Clinical Investigative Site 5204, Mainz

58185

Clinical Investigative Site 6003, Linköping

61018

Clinical Investigative Site 6110, Kharkiv

61035

Clinical Investigative Site # 6101, Kharkiv

61761

Clinical Investigative Site 6213, Normal

63141

Clinical Investigative Site # 6209, St Louis

63571

Clinical Investigative Site 5207, Gelnhausen

64239

Clinical Investigative Site # 5404, Tel Aviv

Clinical Investigative Site # 5406, Tel Aviv

65025

Clinical Ivestigative Site 6111, Odesa

69035

Clinical Investigative Site 6105, Zaporizhia

69118

Clinical Investigative Site # 6106, Zaporizhia

70112

Clinical Investigative Site # 6215, New Orleans

76100

Clinical Investigative Site # 5403, Rehovot

76132

Clinical Investigative Site # 6225, Fort Worth

78229

Clinical Investigative Site # 6222, San Antonio

Clinical Investigative Site 6229, San Antonio

78278

Clinical Investigative Site # 5407, Ashkelon

79903

Clinical Investigative Site # 6220, El Paso

83099

Clinical Investigative Site # 6104, Donetsk

87182

Clinical Investigative Site # 6006, Härnösand

88009

Clinical Investigative Site # 6107, Uzhhorod

90025

Clinical Investigative Site # 6204, Los Angeles

90095

Clinical Investigative Site 6208, Los Angeles

91120

Clinical Investigative Site # 5402, Jerusalem

97035

Clinical Inverstigative Site #6201, Lake Oswego

97213

Clinical Investigative Site # 6214, Portland

97231

Clinical Investigative Site # 6002, Luleå

97504

Clinical Investigative Site # 6207, Medford

105077

Clinical Investigative Site 5602, Moscow

105229

Clinical Investigative Site 5654, Moscow

115280

Clinical Investigative Site 5607, Moscow

194044

Clinical Investigative Site 5605, Saint Petersburg

197022

Clinical Investigative Site 5604, Saint Petersburg

420015

Clinical Investigative Site 5603, Kazan'

529889

Clinical Investigative Site 5802, Singapore

630037

Clinical Investigative Site 5609, Novosibirsk

634034

Clinical Investigative Site 5608, Tomsk

656024

Clinical Investigative Site 5610, Barnaul

656045

Clinical Investigative Site 5606, Barnaul

02747

Clinical Investigative Site # 6211, North Dartmouth

H-9700

Clinical Investigative Site # 5305, Szombathely

H-2800

Clinical Investigative Site 5302, Tatabánya

15-010

Clinical Investigative Site # 5507, Bialystok

31-023

Clinical Investigative Site # 5505, Krakow

90-553

Clinical Investigative Site # 5501, Lodz

20-095

Clinical Investigative Site # 5502, Lublin

33-100

Clinical Investigative Site # 5503, Tarnów

0157

Clinical Investigative Site 5903, Pretoria

0181

Clinical Investigative Site 5907, Pretoria

413 42

Clinical Investigative Site 6001, Gothenburg

111 57

Clinical Investigative Site 6007, Stockholm

432 44

Clinical Investigative Site 6004, Varberg

03680

Clinical Investigative Site # 6102, Kyiv

Clinical Investigative Site # 6103, Kyiv

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY